| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 10/07/2004 | US20040198717 4-(trifluoromethyl)-7,8,9,10-tetrahydrochromeno[7,6-b]azepin-2(6H)-one and derivatives;4-(trifluoromethyl)-1,6,7,8,9,10-hexahydro-2H-azepino[3,2-g]quinolin-2-one and derivatives; useful in the treating conditions caused by androgen deficiency such as bone disorders |
| 10/07/2004 | US20040198716 Cysteine protease inhimbitors |
| 10/07/2004 | US20040198709 Compositions and methods for enhancing corticosteroid delivery |
| 10/07/2004 | US20040198696 Agent and food for inhibiting IgE antibody |
| 10/07/2004 | US20040198688 for treatment of atopic conditions (dermatitis, allergies); point mutations |
| 10/07/2004 | US20040198682 RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (siNA) |
| 10/07/2004 | US20040198677 macrolide and steroidal or non-steroidal substructures connected by an alkyl linker; esterification or amidation to couple; antiarthritic, antiasthmatic agents, nasal, gastrointestinal, dermatological and opthalmic disorders; veterinary or human therapy |
| 10/07/2004 | US20040198651 Secreted proteins |
| 10/07/2004 | US20040198633 Fungicide against Candida, Entomocorticum, Stereum, Phellinus, Peniophora, Xilaria, Rosellinia, Multiclavula, Hericium, and/or Tricholoma; flucytosine, miconazole,ketoconazole, fluconazole, amphotericin B extracted from culture of Streptomyces and/or nystatin |
| 10/07/2004 | US20040197887 MIxtures of oxidoreductase enzymes, nicotinamido adenine dinucleotide coenzyme and vasodilators, complexed with phosphatides in solution, used for prophylaxis of hair loss |
| 10/07/2004 | US20040197876 Recombinant fusion proteins and the trimers thereof |
| 10/07/2004 | US20040197847 High throughput screening assays using fatty acid synthetic enzymes |
| 10/07/2004 | US20040197786 Method of examining steroid resnponsiveness |
| 10/07/2004 | US20040197416 contains dehydroepiandrosterone (DHEA) or its derivatives, aqueous medium, a polymer shell and a lipid core containing an oily solvent |
| 10/07/2004 | US20040197410 uniformly contains pullulan and a non-reducing saccharide(s) composed of glucose units, has an improved rate of water dissolution, and retains a satisfactory resistance to humidity; culturing a microorganism capable of producing pullulan followed by purification |
| 10/07/2004 | US20040197361 Mixture containing fatty ester of (di- or tri) alkylene glycol; therapy for skin disorders |
| 10/07/2004 | US20040197345 Prostate derived Ets factor |
| 10/07/2004 | US20040197335 Non-myeloablative tolerogenic treatment with tyrphostins |
| 10/07/2004 | US20040197307 Mixture of human interferons |
| 10/07/2004 | US20040197294 Cosmetic and/or pharmaceutical preparations |
| 10/07/2004 | US20040197283 Vitamin/metal salt compositions for reducing hair loss and/or promoting hair regrowth |
| 10/07/2004 | US20040197282 Method and preparation containing idebenone for protecting human skin |
| 10/07/2004 | CA2520443A1 Methods for treating inflammatory conditions or inhibiting jnk |
| 10/07/2004 | CA2520147A1 Compound having affinity with calcified tissue |
| 10/07/2004 | CA2520057A1 Composition for promoting production of type i collagen and/or elastin |
| 10/07/2004 | CA2520009A1 Oxamide derivatives useful as raf-kinase inhibitors |
| 10/06/2004 | EP1464673A2 Polyanhydrides with biologically active degradation products |
| 10/06/2004 | EP1464646A1 Thieno(2,3-C) Isoquinolines for use as inhibitors of Parp |
| 10/06/2004 | EP1464640A2 20-Epi-16-ene-25-OH-D3-analogs |
| 10/06/2004 | EP1464330A1 Use of a composition containing oligosaccharides in combination with a saponine or a basic aminoacid, for topical administration or for inhalation |
| 10/06/2004 | EP1463823A2 Methods of increasing endogenous erythropoietin (epo) |
| 10/06/2004 | EP1463799A2 Methods for the induction of professional and cytokine-producing regulatory cells |
| 10/06/2004 | EP1463756A2 Secreted proteins |
| 10/06/2004 | EP1463728A2 Fused cyclic modulators of nuclear hormone receptor function |
| 10/06/2004 | EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 10/06/2004 | EP1463714A2 Vanilloid receptor ligands and their use in treatments |
| 10/06/2004 | EP1463707A2 A group of novel anti-cancer compounds with specific structure |
| 10/06/2004 | EP1463539A1 Controlled release therapeutic wound dressings |
| 10/06/2004 | EP1463531A1 Methods for inhibiting ocular processes |
| 10/06/2004 | EP1463525A2 Compositions and methods for the diagnosis and treatment of tumor |
| 10/06/2004 | EP1463509A1 Type 4 phosphodiesterase inhibitors and uses thereof |
| 10/06/2004 | EP1463507A1 Thienopyrimidine compounds as protein tyrosine kinase inhibitors |
| 10/06/2004 | EP1463498A1 Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases |
| 10/06/2004 | EP1463491A1 Thin film with non-self-aggregating uniform heterogeneity, process for ther production and drug delivery systems made therefrom |
| 10/06/2004 | EP1463487A1 Liposomal delivery of vitamin e based compounds |
| 10/06/2004 | EP1463483A1 New composition |
| 10/06/2004 | EP1309309B1 Dermatological composition |
| 10/06/2004 | EP1303251B1 Composition, in particular cosmetic, containing dhea and/or a chemical or biological precursor or derivative thereof, and a metalloproteinase inhibitor |
| 10/06/2004 | EP1282395B1 Use of ellagic acid as anti-pollution cosmetic agent |
| 10/06/2004 | EP1248787B1 NOVEL SUBTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM |
| 10/06/2004 | EP1210325B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 10/06/2004 | EP1202743B1 Pharmaceutical and cosmetic compositions comprising cod serine proteases and their pharmaceutical and cosmetic use |
| 10/06/2004 | EP1173147B1 Sunscreen agents containing hydroxycarboxylic acid alkyl,-and/or alkenyloligo- glycoside esters |
| 10/06/2004 | EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 10/06/2004 | EP1135163B1 Topical compositions comprising ascomycins |
| 10/06/2004 | EP0964667B1 Bar composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers |
| 10/06/2004 | EP0869810B1 Cyclosporin-containing soft capsule preparations |
| 10/06/2004 | EP0840608B1 Orotate salts of 5-amino or substituted amino 1,2,3-triazoles for treatment of neoplasms |
| 10/06/2004 | CN1535281A Peptides and related molecules that bind to TALL-1 |
| 10/06/2004 | CN1535162A External preparation for skin |
| 10/06/2004 | CN1535156A Use of disintegrain domain of adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 10/06/2004 | CN1535149A Topical application of thiazolyl amides |
| 10/06/2004 | CN1535143A Use of MGLUR 5 antagonists for treatment of pruritic conditions |
| 10/06/2004 | CN1534028A New azadicyclo salt kind compound and its use in treating protein aging disease |
| 10/06/2004 | CN1534017A N-(2-phenyl-4-amino-batyl)-1-naphthol carboxy amide kind compound used as neuropeptide-1-acceptor antagonistic agent |
| 10/06/2004 | CN1533802A Wart eliminating composition and its preparation method |
| 10/06/2004 | CN1533792A Medicine for treating itchy skin |
| 10/06/2004 | CN1533786A Blood quickening statis transforming plaster |
| 10/06/2004 | CN1533781A Juanzaiping (residue eliminating) ointment |
| 10/06/2004 | CN1533779A New medicine for treating beriberi |
| 10/06/2004 | CN1533777A External use medicine for treating bromhidrosis |
| 10/06/2004 | CN1533762A Bionic skin and vagine nursing liquid |
| 10/06/2004 | CN1169959C Polypeptide variants with raised heparin-binding capacity |
| 10/06/2004 | CN1169838C Acetyl mannan and its preparing method and use |
| 10/06/2004 | CN1169808C 'Beta'-carboline compound |
| 10/06/2004 | CN1169793C Process for producing bis (4-amino-1-pyridine) paraffins |
| 10/06/2004 | CN1169768C (4-alkynyl), aromatic keto-acid compound, synthesis method and its application |
| 10/06/2004 | CN1169576C Recombinant human granulocyte-macrophage colony stimulating factor gel |
| 10/06/2004 | CN1169562C External use ointment for restoring period of knocks and falls |
| 10/06/2004 | CN1169552C Ointment for curing skin wart |
| 10/06/2004 | CN1169537C Traditional Chinese medicine for treating psoriasis |
| 10/06/2004 | CN1169531C Process for producing freezed dried centipede |
| 10/06/2004 | CN1169518C Multifunctional cosmetics |
| 10/06/2004 | CN1169517C Spot eliminating ointment |
| 10/06/2004 | CN1169514C Use of compound for improving skin and its mucous membrane physical-chemical property to prevent adsorption of microorganism |
| 10/05/2004 | US6800762 Indolin derivaties as sun protection agents |
| 10/05/2004 | US6800654 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 10/05/2004 | US6800653 Anticancer agents |
| 10/05/2004 | US6800645 Substituted azabicyclic compounds |
| 10/05/2004 | US6800644 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds |
| 10/05/2004 | US6800632 Bicyclic inhibitors of glycogen synthase kinase 3 |
| 10/05/2004 | US6800626 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc. |
| 10/05/2004 | US6800620 Contacting leukocytes, osteoclasts with an enzyme inhibitors, a 9h-purin-3h-quinazolin-4-one derivatives, treating bone-resorption disorder, antiproliferative agents treating leukemia cells |
| 10/05/2004 | US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 10/05/2004 | US6800613 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds |
| 10/05/2004 | US6800609 Isolated peptide of the horny layer and user thereof |
| 10/05/2004 | US6800605 With a hypolipidemic agent, an antidiabetic agent, an antidepressant, a bone resorption inhibitor, an appetite suppressant and/or an anti-obesity agent |
| 10/05/2004 | US6800471 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 10/05/2004 | US6800446 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 10/05/2004 | US6800290 Variants can be used in specific immunotherapy of allergic pathologies caused by dust mites |